FOI release

Freedom of Information request on FOI 22/495

Published 1 June 2022

FOI 22/495

21st March 2022

Dear

Thank you for your email.

This information would be exempt under Section 41 and Section 43 of the Freedom of Information Act.

Section 41 is an absolute exemption and no consideration of the public interest is required, except to state that we would consider the release of this information to be an actionable breach.

Section 43 is a qualified exemption and a consideration of the public interest is required. We have considered the public interest and cannot see any public interest arguments that outweigh the commercial harm in providing information that can aid a competitor in their product development and help them overcome regulatory hurdles to get their product onto the marketing quicker.

If you have a query about the information provided, please reply to this email.

Please remember to quote the reference number above in any future communications.

If you were to remain dissatisfied with the outcome of the internal review, you would have the right to apply directly to the Information Commissioner for a decision. Please bear in mind that the Information Commissioner will not normally review our handling of your request unless you have first contacted us to conduct an internal review. The Information Commissioner can be contacted at:

Information Commissioner’s Office

Wycliffe House

Water Lane

Wilmslow

Cheshire

SK9 5AF

Yours sincerely

MHRA Customer Experience Centre

Communications and engagement team

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU Telephone 020 3080 6000